Unlocking the Potential of Tulisokibart & Harnessing Biomarkers to Elevate Response Rate for Therapeutics in IBD
Time: 9:30 am
day: Day One
Details:
- Sharing insights from the integration of a diagnostic tool in a phase II trial, highlighting successes, challenges, and learnings from its development
- Discussing the role of patient stratification in advancing therapeutic precision and optimizing treatment pathways for IBD
- Exploring the future potential of diagnostic innovations in clinical trials and their role in shaping precision medicine strategies
